We know that adolescent girls and young women live complex lives full of important relationships that shape the decisions they make. Yet too often efforts to generate demand for PrEP fail to reach beyond the individual user to her support system—those trusted people in her life who she leans on when making important choices. But demand generation for PrEP is evolving.

Since oral PrEP was first approved for use in 2012, dozens of countries have approved the product and use is expanding. But the pace of scale-up has been slower than expected and PrEP remains out of reach for many who may benefit from it.

This workshop will explore what is needed to ensure that introductory research and programs are strategically designed, user-centered, and appropriately resourced to support successful rollout of CAB PrEP.

As we move toward a multi-product HIV prevention market, adolescent girls and young women must be empowered to choose an HIV prevention product that meets their needs.

In this webinar, we explore ongoing and completed research on CAB PrEP, learn about the recently released FDA guidance, and hear from a panel of implementers and policymakers on what is needed to advance introduction of this new HIV prevention product.